K.J. Mason

1.9k total citations
39 papers, 781 citations indexed

About

K.J. Mason is a scholar working on Immunology, Dermatology and Economics and Econometrics. According to data from OpenAlex, K.J. Mason has authored 39 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Dermatology and 8 papers in Economics and Econometrics. Recurrent topics in K.J. Mason's work include Psoriasis: Treatment and Pathogenesis (19 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Dermatology and Skin Diseases (7 papers). K.J. Mason is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (19 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Dermatology and Skin Diseases (7 papers). K.J. Mason collaborates with scholars based in United Kingdom, Australia and Egypt. K.J. Mason's co-authors include Catherine Smith, Richard B. Warren, C.E.M. Griffiths, Mark Lunt, Nick J. Reynolds, Kathleen McElhone, John G. Stell, Matt Duckham, Michael Worboys and Zenas Z N Yiu and has published in prestigious journals such as Pain, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

K.J. Mason

34 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.J. Mason United Kingdom	15	490	294	124	123	105	39	781
Margaret Gamalo United States	14	124 0.3×	623 2.1×	240 1.9×	84 0.7×	140 1.3×	52	1.2k
H. Amy Xia United States	15	284 0.6×	116 0.4×	151 1.2×	81 0.7×	175 1.7×	27	776
Sivem Afach France	9	330 0.7×	203 0.7×	57 0.5×	40 0.3×	75 0.7×	17	452
Marc Vandemeulebroecke Switzerland	13	868 1.8×	152 0.5×	264 2.1×	112 0.9×	211 2.0×	36	1.9k
Jiacheng Yuan United States	10	509 1.0×	102 0.3×	402 3.2×	57 0.5×	61 0.6×	21	872
Quinn Thibodeaux United States	13	311 0.6×	303 1.0×	86 0.7×	66 0.5×	8 0.1×	37	687
Sue‐Jane Wang United States	24	175 0.4×	34 0.1×	22 0.2×	64 0.5×	470 4.5×	73	1.9k
Vidhatha Reddy United States	9	204 0.4×	152 0.5×	57 0.5×	37 0.3×	8 0.1×	24	468
Juan Ding United States	19	39 0.1×	134 0.5×	18 0.1×	31 0.3×	33 0.3×	56	1.1k
Matt Hutmacher United States	11	77 0.2×	43 0.1×	69 0.6×	18 0.1×	92 0.9×	15	618

Countries citing papers authored by K.J. Mason

Since Specialization

Citations

This map shows the geographic impact of K.J. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.J. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.J. Mason more than expected).

Fields of papers citing papers by K.J. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.J. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.J. Mason. The network helps show where K.J. Mason may publish in the future.

Co-authorship network of co-authors of K.J. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of K.J. Mason. A scholar is included among the top collaborators of K.J. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.J. Mason. K.J. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mason, K.J., Kelvin P. Jordan, James Bailey, et al.. (2025). Trends of musculoskeletal pain in children and young people consulting primary care: an electronic primary health care record study. BMC Pediatrics. 25(1). 961–961.

Heron, Neil, et al.. (2025). Efficacy of orlistat in type 2 diabetes: a systematic review and meta-analysis. BJGP Open. 9(4). BJGPO.2025.0058–BJGPO.2025.0058.

Mason, K.J., Kelvin P. Jordan, James Bailey, et al.. (2024). P051 Trends in consultations for musculoskeletal pain in children and young people presenting to United Kingdom primary care: an electronic health record study. Lara D. Veeken. 63(Supplement_1). 1 indexed citations

Heron, Neil, et al.. (2024). Weight management with orlistat in type 2 diabetes: an electronic health records study. British Journal of General Practice. 74(748). 758–766. 2 indexed citations

Png, May Ee, K.J. Mason, Michelle Marshall, et al.. (2023). Estimating the direct healthcare utilization and cost of musculoskeletal pain among people with comorbidity: a retrospective electronic health record study. Current Medical Research and Opinion. 39(11). 1473–1480.

Marshall, Michelle, K.J. Mason, John Edwards, et al.. (2023). Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study. Rheumatology Advances in Practice. 8(1). rkad104–rkad104. 2 indexed citations

Mason, K.J., Kelvin P. Jordan, Neil Heron, et al.. (2023). Musculoskeletal pain and its impact on prognosis following acute coronary syndrome or stroke: A linked electronic health record cohort study. Musculoskeletal Care. 21(3). 749–762. 2 indexed citations

Gonçalves, Isabel, et al.. (2023). PB1332 Heightened Thrombosis in Immune Thrombocytopenia: Insights into the Risk Factors and Clinical Outcomes from an Australian Hospital Cohort. Research and Practice in Thrombosis and Haemostasis. 7. 101448–101448. 1 indexed citations

Burton, Claire, Ram Bajpai, K.J. Mason, et al.. (2023). The impact of the COVID-19 pandemic on referrals to musculoskeletal services from primary care and subsequent incidence of inflammatory rheumatic musculoskeletal disease: an observational study. Rheumatology Advances in Practice. 7(2). rkad044–rkad044. 2 indexed citations

10.

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology. 35(8). e496–e498. 3 indexed citations

11.

Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology. 35(8). e498–e501. 4 indexed citations

12.

Yiu, Zenas Z N, K.J. Mason, Philip Hampton, et al.. (2020). Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). British Journal of Dermatology. 183(2). 294–302. 74 indexed citations

13.

Yiu, Zenas Z N, K.J. Mason, Juliet N. Barker, et al.. (2019). A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. British Journal of Dermatology. 181(6). 1265–1271. 16 indexed citations

14.

Mason, K.J., Zenas Z N Yiu, Kathleen McElhone, et al.. (2019). Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review. British Journal of Dermatology. 181(2). 256–264. 16 indexed citations

15.

García‐Doval, I., M.Á. Descalzo, K.J. Mason, et al.. (2018). Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland. British Journal of Dermatology. 179(4). 863–871. 21 indexed citations

16.

Mason, K.J., Terence W O’Neill, Mark Lunt, Anthony Jones, & John McBeth. (2018). Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain. Scandinavian Journal of Pain. 18(1). 59–69. 17 indexed citations

17.

Mason, K.J., Mark Lunt, Kathleen McElhone, et al.. (2018). 509 Association between biologics and major cardiovascular events in adult patients with plaque psoriasis: A cohort study in the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology. 138(5). S87–S87. 1 indexed citations

18.

Warren, Richard B., Antonia Marsden, Barbara Tomenson, et al.. (2018). Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study. British Journal of Dermatology. 180(5). 1069–1076. 65 indexed citations

19.

Mason, K.J., Mark Lunt, H.J.A. Hunter, et al.. (2017). Real-world use of fumaric acid esters in psoriasis: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). British Journal of Dermatology. 177(5). 1 indexed citations

20.

Mason, K.J., Lau Caspar Thygesen, Egon Stenager, Henrik Brønnum‐Hansen, & Nils Koch‐Henriksen. (2011). Evaluating the use and limitations of the Danish National Patient Register in register-based research using an example of multiple sclerosis. Acta Neurologica Scandinavica. 125(3). 213–217. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact